| # | Drug | Count |
|---|---|---|
| 0 | BACLOFEN | 140 |
| 1 | EPOPROSTENOL | 61 |
| 2 | TREPROSTINIL | 49 |
| 3 | SILDENAFIL CITRATE | 40 |
| 4 | AMBRISENTAN | 37 |
| 5 | MORPHINE | 37 |
| 6 | TADALAFIL | 29 |
| 7 | GABAPENTIN | 28 |
| 8 | BUPIVACAINE | 26 |
| 9 | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE | 26 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | AIR | 1 | 0.0476 |
| 1 | DEXTROSE AND SODIUM CHLORIDE | 1 | 0.0060 |
| 2 | EPOPROSTENOL | 61 | 0.0047 |
| 3 | NEOMYCIN AND POLYMYXIN B SULFATES AND HYDROCORTISONE | 1 | 0.0038 |
| 4 | BUPIVACAINE HYDROCHLORIDE IN DEXTROSE | 26 | 0.0034 |
| 5 | BACLOFEN INJECTION | 10 | 0.0032 |
| 6 | BUPIVACAINE | 26 | 0.0028 |
| 7 | SODIUM MONOFLUOROPHOSPHATE | 1 | 0.0027 |
| 8 | DOCUSATE SODIUM 50 MG SENNOSIDES 8.6 MG | 2 | 0.0026 |
| 9 | SENNOSIDES 8.6MG AND DOCUSATE SODIUM 50MG | 2 | 0.0026 |
| # | Drug class | Count |
|---|---|---|
| 0 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 148 |
| 1 | Prostacycline Vasodilator [EPC] | 105 |
| 2 | Endothelin Receptor Antagonist [EPC] | 58 |
| 3 | Opioid Agonist [EPC] | 55 |
| 4 | Phosphodiesterase 5 Inhibitor [EPC] | 43 |
| 5 | Benzodiazepine [EPC] | 37 |
| 6 | Amide Local Anesthetic [EPC] | 29 |
| 7 | Nonsteroidal Anti-inflammatory Drug [EPC] | 29 |
| 8 | Progestin [EPC] | 27 |
| 9 | Aromatic Amino Acid [EPC] | 24 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | gamma-Aminobutyric Acid-ergic Agonist [EPC] | 148 | 0.0017 |
| 1 | Vitamin D2 Analog [EPC] | 7 | 0.0010 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 3 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 1 | 0.0008 |
| 4 | Prostacycline Vasodilator [EPC] | 105 | 0.0008 |
| 5 | Provitamin D2 Compound [EPC] | 16 | 0.0005 |
| 6 | alpha-Hydroxy Acid [EPC] | 1 | 0.0005 |
| 7 | Aromatic Amino Acid [EPC] | 24 | 0.0004 |
| 8 | Catechol-O-Methyltransferase Inhibitor [EPC] | 2 | 0.0004 |
| 9 | Vitamin D Analog [EPC] | 7 | 0.0004 |